After operating two separate financial firms for two decades, Gottlieb and Weisbrod have decided to work together in one office. The two gentlemen who are experts in medicine and healthcare are familiar with each other having worked together previously. They were working as colleagues at Merlin Med Group.
Merlin Group was founded back in the year 1998 whose aim was to manage investment which was focused on medicine and the healthcare industry. Healthcare sector had different portfolios such as medical device, pharmaceutical, biotechnology, and healthcare services. Weisbrod track record in healthcare and biotechnology was awesome. He held positions with Harpel Partners, Oracle Partners, Prudential Securities, and Merrill Lynch. His academic record was good as well. He is a PhD holder in Biochemistry from the University of Princeton. He also holds an MBA in Accounting and Finance from the University of Columbia. Initially, he had studied Chemistry at the University of Colgate.
His professional background gave him the necessary skills and experience in building a professional winning team. He built a team like Jacob Gottlieb who performed the duties and roles of a portfolio manager. Jacob worked for Merlin in the biotechnology department where he helped this company to achieve great returns between 1999 and 2000. On the other hand, Gottlieb and his fellow portfolio managers played the role of generating great returns which helped to get prominent customers such as family offices, endowments, pension funds, and other private individuals.
Shortly Merlin company collapsed and Weisbrod went to set up a new firm known as iguana healthcare partners. The objectives of iguana healthcare partners were the same as those of Merlin. In mainly focused on public affairs such as healthcare information, healthcare services, medical device, diagnostic, pharmaceutical and biotechnology.
As Weisbrod went to set his new firm, Gottlieb also went and created his own firm after he left Merlin. He succeeded in the financial sector and he founded an asset management firm which cost was $350 million. His asset management firm came to stand still in the year 2016.
The two experienced financial entrepreneurs have now decided to work from the same office. The company is hopeful to get good results and great investment opportunities for the healthcare sector.